- Home
- GTY vs CLDX Comparison
GTY vs CLDX Comparison
Compare GTY & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTY
- CLDX
- Stock Information
- Founded
- GTY 1955
- CLDX N/A
- Country
- GTY United States
- CLDX United States
- Employees
- GTY N/A
- CLDX N/A
- Industry
- GTY Real Estate
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- GTY Finance
- CLDX Health Care
- Exchange
- GTY Nasdaq
- CLDX Nasdaq
- Market Cap
- GTY 1.6B
- CLDX 1.3B
- IPO Year
- GTY N/A
- CLDX 2008
- Fundamental
- Price
- GTY $28.38
- CLDX $19.52
- Analyst Decision
- GTY Buy
- CLDX Buy
- Analyst Count
- GTY 6
- CLDX 9
- Target Price
- GTY $33.00
- CLDX $55.50
- AVG Volume (30 Days)
- GTY 401.8K
- CLDX 702.8K
- Earning Date
- GTY 04-23-2025
- CLDX 05-08-2025
- Dividend Yield
- GTY 6.64%
- CLDX N/A
- EPS Growth
- GTY 2.68
- CLDX N/A
- EPS
- GTY 1.20
- CLDX N/A
- Revenue
- GTY $206,751,000.00
- CLDX $7,020,000.00
- Revenue This Year
- GTY $7.70
- CLDX N/A
- Revenue Next Year
- GTY $7.93
- CLDX N/A
- P/E Ratio
- GTY $23.59
- CLDX N/A
- Revenue Growth
- GTY 7.80
- CLDX 1.99
- 52 Week Low
- GTY $25.70
- CLDX $14.40
- 52 Week High
- GTY $33.85
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- GTY 45.98
- CLDX 51.17
- Support Level
- GTY $27.69
- CLDX $17.85
- Resistance Level
- GTY $28.44
- CLDX $21.23
- Average True Range (ATR)
- GTY 0.59
- CLDX 1.08
- MACD
- GTY 0.11
- CLDX 0.00
- Stochastic Oscillator
- GTY 62.63
- CLDX 44.77
About GTY Getty Realty Corporation
Getty Realty Corp is the real estate investment trust in the U.S. specializing in the acquisition, financing, and development of convenience, automotive, and other single tenant retail real estate. The company's portfolio includes convenience stores, car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, collision), automotive parts retailers, and certain other freestanding retail properties, including drive-thru quick service restaurants. It generates majority of the revenue in the form of rental income.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.